Chambres anéchoïques : l'apport des antennes réseau = Anechoic room: array antenna contributionNAUD, P; MORVAN, S; GERMAIN, G et al.Essais industriels. 2000, Num 13, pp 10-18, issn 1290-0206Article

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult womenDE CARVALHO, N; TEIXEIRA, J; ROTELI-MARTINS, C. M et al.Vaccine. 2010, Vol 28, Num 38, pp 6247-6255, issn 0264-410X, 9 p.Article

Clinical trials of cancer screening in the developing world and their impact on cancer healthcareSANKARANARAYANAN, R; SAUVAGET, C; RAMADAS, K et al.Annals of oncology. 2011, Vol 22, issn 0923-7534, vii20-vii28, SUP7Conference Paper

Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPAAVONEN, J; NAUD, P; HEDRICK, J et al.Lancet (British edition). 2009, Vol 374, Num 9686, pp 301-314, issn 0140-6736, 14 p.Article

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15―25 years with and without serological evidence of previous exposure to HPV-16/18SZAREWSKI, A; POPPE, W. A. J; CASTELLSAGUE, X et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 106-116, issn 0020-7136, 11 p.Article

Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening StudiesSYRJANEN, K; SHABALOVA, I; TATTI, S et al.International journal of STD & AIDS. 2011, Vol 22, Num 6, pp 315-323, issn 0956-4624, 9 p.Article

Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia : case-control study nested within the Latin American Screening study cohortSYRJÄNEN, K; NAUD, P; GONTIJO, R et al.International journal of STD & AIDS. 2008, Vol 19, Num 4, pp 251-258, issn 0956-4624, 8 p.Article

Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3SYRJÄNEN, K; SHABALOVA, I; KLJUKINA, L et al.International journal of STD & AIDS. 2011, Vol 22, Num 5, pp 263-272, issn 0956-4624, 10 p.Article

Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of BrazilNAUD, P; MATOS, J; COSTA, M et al.European journal of obstetrics, gynecology, and reproductive biology. 2006, Vol 124, Num 1, pp 110-118, issn 0301-2115, 9 p.Article

Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS studySYRJÄNEN, K; NAUD, P; GONTIJO, R et al.Anticancer research. 2005, Vol 25, Num 5, pp 3469-3480, issn 0250-7005, 12 p.Article

Moyens de mesure de la surface équivalente radar = RCS measurement facilitiesGARAT, J; NAUD, P; PRULHIERE, J. P et al.Chocs (Villeneuve-Saint-Georges). 1993, Num 8, pp 65-74, issn 1157-741XArticle

Page / 1